N/A N=12 Supportive Care

Clinical Study of Peripheral Capillary Oxygen Saturation (SpO2): Vital Signs Patch (VSP)

Desaturation of Blood

Bottom Line

View on ClinicalTrials.gov: NCT01899911 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2015

Primary outcome: Primary: Composite Outcome Measure: Successful Capture of Peripheral Capillary Oxygen Saturation (SpO2) Level — 12 participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Vital Signs Patch (VSP) (Device)
Age: Adult · 23+ yrs
Sex: All
Sponsor: LifeWatch Services, Inc.
Primary completion: Mar 2013

Outcome Measures

Outcome	Result	p-value
PRIMARY Composite Outcome Measure: Successful Capture of Peripheral Capillary Oxygen Saturation (SpO2) Level	12	—

Summary

A clinical study designed to determine the accuracy of the peripheral capillary oxygen saturation (SpO2) function of the Vital Signs Patch (VSP) device for measuring blood saturation level.

Eligibility Criteria

Inclusion Criteria

Ages 23 to 33.
Skin tone varied from light to dark.

Exclusion Criteria

Smokers
Anemic

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01899911). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.